Results 41 to 50 of about 19,249 (228)

A perioperative uncontrollable bleeding in an elderly patient with acquired hemophilia A: a case report [PDF]

open access: yes, 2013
Acquired hemophilia A should be taken into account in the differential diagnosis of perioperative bleeding in patients without any apparent reason for activated partial thromboplastin time ...
CORTEGIANI, Andrea   +6 more
core   +1 more source

On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience [PDF]

open access: yes, 2010
Background: Manifestation of acute edema in hereditary angioedema (HAE) is characterized by interindividual and intraindividual variability in symptom expression over time. Flexible therapy options are needed.
Aygören-Pürsün, Emel   +4 more
core   +2 more sources

Acquired hemophilia: a case report

open access: yesPolish Archives of Internal Medicine, 2008
Acquired hemophilia is a severe bleeding diathesis that affects both males and females. It is caused by suddenly appearing autoantibodies that interfere with coagulation factor VIII activity. This disorder is characterized by spontaneous and post-traumatic subcutaneous bleeds and massive mucosal hemorrhages.
Mariusz, Flisiński   +5 more
openaire   +2 more sources

Acquired hemophilia A presenting post partum [PDF]

open access: yesCanadian Medical Association Journal, 2007
The case: A 41-year-old woman (gravida 4, para 3) presented in labour after 39 weeks' gestation. Her medical history included myasthenia gravis and thymectomy in 1995 and immunosuppression with azathioprine, which was stopped at 12 weeks' gestation.
Kristine, Mytopher   +3 more
openaire   +2 more sources

Retrobulbar Hemorrhage Secondary to Acquired Hemophilia A [PDF]

open access: yesCureus, 2021
Acquired hemophilia A (AHA) is a different bleeding disorder to that of classic hemophilia A. It is an autoimmune-mediated bleeding disorder due to the presence of autoantibodies (inhibitors) directed against plasma coagulation factor VIII. This can result in fatal hemorrhage; thus, eradication of the antibody is the mainstay of treatment. Nontraumatic
Jayasundara, Hishali D   +2 more
openaire   +2 more sources

Haemophilia and joint disease: pathophysiology, evaluation and management [PDF]

open access: yes, 2011
In patients with haemophilia, regular replacement therapy with clotting factor concentrates (prophylaxis) is effective in preventing recurrent bleeding episodes into joints and muscles.
Berntorp, Erik, Knobe, Karin
core   +3 more sources

Treatment of acquired hemophilia A [PDF]

open access: yesJournal of Thrombosis and Haemostasis, 2007
Acquired hemophilia A (AH) is an autoimmune disease that leads to potentially severe bleeding. Management relies on rapid and accurate diagnosis, control of bleeding episodes and eradication of the inhibitor by immunosuppression. There is extensive literature about the disease but only few controlled data are available.
openaire   +2 more sources

Hemophilia in the newborn without family history: Pattern of clinical presentation of three patients [PDF]

open access: yes, 2010
Introduction. Hemophilia is the most frequently diagnosed inborn clotting factor deficiency in the newborn. In about half of the cases diagnosis is made during neonatal period.
Janković Borisav   +4 more
core   +1 more source

Acquired Hemophilia Caused by Ureteral Tumor [PDF]

open access: yes, 2018
K
Berczi, Csaba   +4 more
core   +1 more source

Acquired hemophilia A

open access: yesHematology, 2006
Acquired hemophilia A is a rare but severe autoimmune bleeding disorder, resulting from the presence of autoantibodies directed against clotting factor VIII. The etiology of the disorder remains obscure, although approximately half of all cases are associated with other underlying conditions.
openaire   +2 more sources

Home - About - Disclaimer - Privacy